Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2025 »
Home
Forums
Diabetes Discussion
Type 1 Diabetes
Afrezza inhaled fast acting insulin
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="tim2000s" data-source="post: 801411" data-attributes="member: 30007"><p>[USER=12578]@phoenix[/USER] Well said. I've been doing some digging on the web to try and verify the claims that have been spammed by [USER=167280]@mountainman[/USER] . So far all I can find are the afrezzauser blog (which seems to be Sam) and a couple of other users. There is precious little evidence from PWD about using the product and there is very clear evidence in the FDA trials (which Afrezza failed twice) that the product can have a side effect on lungs.</p><p></p><p>From an investment perspective, sales of Afrezza have been disappointing in the first month on general release in the US (hence the investor spamming that has been seen) and analysts have downgraded the performance of MannKind, making the stock less attractive. </p><p></p><p>I can find no negative feedback from any PWD on Afrezza, probably due to some form of NDA signed when undertaking the market trials, so the positive evidence is currently, in my view, still marketing. </p><p></p><p>There is a currently a phase three clinical trial in operation in the UK and Europe, and we may see further information come about from that later this year.</p><p></p><p>So while the story looks wonderful, the information that is out there is still, in my view, falling into the "Propaganda" category as there is no negative coverage whatsoever. And that is simply not normal.</p></blockquote><p></p>
[QUOTE="tim2000s, post: 801411, member: 30007"] [USER=12578]@phoenix[/USER] Well said. I've been doing some digging on the web to try and verify the claims that have been spammed by [USER=167280]@mountainman[/USER] . So far all I can find are the afrezzauser blog (which seems to be Sam) and a couple of other users. There is precious little evidence from PWD about using the product and there is very clear evidence in the FDA trials (which Afrezza failed twice) that the product can have a side effect on lungs. From an investment perspective, sales of Afrezza have been disappointing in the first month on general release in the US (hence the investor spamming that has been seen) and analysts have downgraded the performance of MannKind, making the stock less attractive. I can find no negative feedback from any PWD on Afrezza, probably due to some form of NDA signed when undertaking the market trials, so the positive evidence is currently, in my view, still marketing. There is a currently a phase three clinical trial in operation in the UK and Europe, and we may see further information come about from that later this year. So while the story looks wonderful, the information that is out there is still, in my view, falling into the "Propaganda" category as there is no negative coverage whatsoever. And that is simply not normal. [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Discussion
Type 1 Diabetes
Afrezza inhaled fast acting insulin
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…